SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-010947
Filing Date
2018-02-21
Accepted
2018-02-21 08:01:32
Documents
56
Period of Report
2018-02-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-6474_18k.htm 8-K 20672
2 EX-99.1 a18-6474_1ex99d1.htm EX-99.1 80391
3 GRAPHIC g64741mmi001.gif GRAPHIC 247452
4 GRAPHIC g64741mmi002.gif GRAPHIC 101292
5 GRAPHIC g64741mmi003.gif GRAPHIC 62016
6 GRAPHIC g64741mmi004.gif GRAPHIC 53823
7 GRAPHIC g64741mmi005.gif GRAPHIC 58588
8 GRAPHIC g64741mmi006.gif GRAPHIC 65306
9 GRAPHIC g64741mmi007.gif GRAPHIC 98332
10 GRAPHIC g64741mmi008.gif GRAPHIC 174931
11 GRAPHIC g64741mmi009.gif GRAPHIC 51608
12 GRAPHIC g64741mmi010.gif GRAPHIC 72522
13 GRAPHIC g64741mmi011.gif GRAPHIC 74164
14 GRAPHIC g64741mmi012.gif GRAPHIC 88150
15 GRAPHIC g64741mmi013.gif GRAPHIC 114646
16 GRAPHIC g64741mmi014.gif GRAPHIC 55022
17 GRAPHIC g64741mmi015.gif GRAPHIC 85939
18 GRAPHIC g64741mmi016.gif GRAPHIC 88050
19 GRAPHIC g64741mmi017.gif GRAPHIC 99697
20 GRAPHIC g64741mmi018.gif GRAPHIC 93649
21 GRAPHIC g64741mmi019.gif GRAPHIC 95484
22 GRAPHIC g64741mmi020.gif GRAPHIC 178269
23 GRAPHIC g64741mmi021.gif GRAPHIC 58062
24 GRAPHIC g64741mmi022.gif GRAPHIC 63851
25 GRAPHIC g64741mmi023.gif GRAPHIC 92184
26 GRAPHIC g64741mmi024.gif GRAPHIC 73949
27 GRAPHIC g64741mmi025.gif GRAPHIC 88622
28 GRAPHIC g64741mmi026.gif GRAPHIC 56635
29 GRAPHIC g64741mmi027.gif GRAPHIC 71940
30 GRAPHIC g64741mmi028.gif GRAPHIC 46714
31 GRAPHIC g64741mmi029.gif GRAPHIC 56970
32 GRAPHIC g64741mmi030.gif GRAPHIC 61848
33 GRAPHIC g64741mmi031.gif GRAPHIC 149674
34 GRAPHIC g64741mmi032.gif GRAPHIC 67295
35 GRAPHIC g64741mmi033.gif GRAPHIC 67536
36 GRAPHIC g64741mmi034.gif GRAPHIC 74276
37 GRAPHIC g64741mmi035.gif GRAPHIC 56238
38 GRAPHIC g64741mmi036.gif GRAPHIC 86798
39 GRAPHIC g64741mmi037.gif GRAPHIC 98233
40 GRAPHIC g64741mmi038.gif GRAPHIC 58610
41 GRAPHIC g64741mmi039.gif GRAPHIC 62140
42 GRAPHIC g64741mmi040.gif GRAPHIC 73448
43 GRAPHIC g64741mmi041.gif GRAPHIC 96239
44 GRAPHIC g64741mmi042.gif GRAPHIC 44999
45 GRAPHIC g64741mmi043.gif GRAPHIC 67760
46 GRAPHIC g64741mmi044.gif GRAPHIC 56486
47 GRAPHIC g64741mmi045.gif GRAPHIC 68221
48 GRAPHIC g64741mmi046.gif GRAPHIC 48268
49 GRAPHIC g64741mmi047.gif GRAPHIC 70367
50 GRAPHIC g64741mmi048.gif GRAPHIC 73618
51 GRAPHIC g64741mmi049.gif GRAPHIC 73655
52 GRAPHIC g64741mmi050.gif GRAPHIC 90875
53 GRAPHIC g64741mmi051.gif GRAPHIC 57330
54 GRAPHIC g64741mmi052.gif GRAPHIC 35568
55 GRAPHIC g64741mmi053.gif GRAPHIC 53582
56 GRAPHIC g64741mmi054.gif GRAPHIC 84586
  Complete submission text file 0001104659-18-010947.txt   6094432
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37558 | Film No.: 18627082
SIC: 2834 Pharmaceutical Preparations